Clinical Trials Symposium, 2024

Clinical Trials Symposium, 2024

Organised by Camina Medical Experts with Avantyo Institute of Clinical Research

The 16th Annual Clinical Trials Symposium, held on 8th November 2024 in Bucharest, revolved around the transformative potential of artificial intelligence in reshaping the future of clinical trials. Organised by Organised by Camina Medical Experts and Avantyo Institute of Clinical Research under the distinguished patronage of EUCROF (the European Contract Research Organisation Federation) and ACCSCR (the Association of Clinical Contract Services and Research in Romania), the event brought together an impressive gathering of specialists, academics, industry leaders, and policymakers to deliberate on cutting-edge innovations and pressing challenges within the global clinical research arena.

One of the central themes explored was the role of Europe—and specifically Romania—within the global clinical trials landscape. Speakers addressed the growing prominence of Asian clinical trials, which have seen an impressive rise in activity, juxtaposed against the waning influence of European contributions. Discussions underscored the need for a cohesive European strategy to bolster its presence in the sector, with Romania emerging as a key player. Insights were shared on Romania’s ongoing efforts to enhance this industry through a dual approach of patient education—helping individuals understand the importance of clinical trials—and fostering the internationalisation of studies to attract global partnerships. Regulatory management and the integration of AI to streamline processes and optimise outcomes were also prominent topics, reflecting the urgency of embracing technological advancements.

A particularly noteworthy session centred on CAR-T cell therapy in oncology, an innovative treatment demonstrating remarkable results in combating blood cancers. Delegates discussed its clinical effectiveness and its transformative potential for patients. However, attention was also drawn to the logistical, financial, and regulatory hurdles that continue to impede the widespread implementation of this therapy within Romania.

Another panel session explored the critical role of decentralised clinical trials (DCT) in the aftermath of the pandemic, which has reshaped healthcare landscapes worldwide. Delegates delved into how decentralised approaches improve patient accessibility, minimise clinic visits, and offer a more inclusive model of participation. The discussion also addressed the integration of artificial intelligence in clinical trial frameworks, particularly for data collection and analysis, whilst acknowledging the associated ethical challenges and the need for robust safeguards.

The symposium reached a meaningful conclusion with a session dedicated to enhancing patient engagement in clinical studies. Barriers such as limited information dissemination, logistical challenges, and the need for support in recruiting patients—especially those residing in rural or underserved areas—were critically examined. Suggestions for tackling these issues included bolstering public awareness campaigns and providing clearer, more transparent communication to prospective participants.

The 16th Annual Clinical Trials Symposium served as an invaluable platform for exchanging ideas and fostering collaboration among industry stakeholders. It reaffirmed the importance of continued innovation and adaptation to emerging technologies to overcome challenges and drive the future of clinical research. The event not only showcased the depth of expertise within the sector but also underscored the collective commitment to advancing medical science for the benefit of patients worldwide.